Rivastigmine Market Trends, Business Overview, Industry Growth and Forecast to 2028
The global rivastigmine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Rivastigmine is a cholinesterase enzyme inhibitor, which acts on butyrylcholinesterase and acetylcholinesterase and it is a cholinergic agent that helps in the treatment of Alzheimer's and Parkinson's disease. The drug can be used in the form of transdermal patches, due to its small cell size. The considerable rise in the number of patients suffering from Alzheimer'sdisease and Parkinson's disease across the globe along with the increase in the level of public awareness about diseases and their symptoms has created a demand for the rivastigmine drug for the treatment of these diseases.The increasing death of neurons, known as neurodegeneration, destroys this vital organism over time and as these connections are disrupted or terminated due to multiple dead cells, patients experience cognitive impairment such as memory loss which worsens with age, they may also experience behavioral changes and mood swings. The Alzheimer's drug control signals by restoring some lost function in cholinergic synapses a connection where one neuron sends a signal or pressure through an axon to the next neuron, which receives it from its dendrites. According to Alzheimer's Disease International (ADI), in 2020, there are over 55 million people living with dementia across the globe. This number will almost double every 20 years, reaching 78 million in 2030 and 139 million in 2050 and as much of the increase will be in developing countries. Already 60.0% of people with dementia live in low and middle-income countries, however, by 2050 this will rise to 71.0%. The fastest growth in the elderly population is taking place in China, India, and their south Asian and western Pacific neighbors.
In addition, according to the Centers for Disease Control and Prevention, Alzheimer's is one of the 10 leading causes of death in the US. The death toll from the disease has risen sharply in the US over the past few years. More than 122k mortalities occurredin the country due to Alzheimer's disease in 2019. Most common among people aged 85 and over, about 5.7 million people are living with Alzheimer's Disease in the US. Looking towards the high demand for drugs that can treat Alzheimer's and Parkinson's disease several healthcare providers are providing approval for the drugs that can be used for the treatment of such diseases.For instance, in June 2021, the US FDA has approved the first treatment of Alzheimer's that is addressing the underlying pathology and the anti-amyloid antibody aducanumab of Biogen and Eisai, now called Aduhelm, this removes amyloid plaque from the brain. Approval of such medications is anticipated to drive the growth of the global rivastigmine market.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Rivastigmine Market at: https://orionmarketreports.com/request-sample/?id=92674&submit=Request+Sample%0D%0A
Market Coverage
•The market number available for - 2021-2028
•Base year- 2021
•Forecast period- 2022-2028
•Segment Covered-
•By Disease Indication
•By Formulation
•By Distribution Channel
•Regions Covered-
•North America
•Europe
•Asia-Pacific
•Rest of the World
Competitive Landscape- Allergan, Eisai Co., Ltd., Novartis AG, Daiichi SankyoCo., Ltd., Merz Pharma, Pfizer Inc., and Johnson & Johnson Services, Inc., among others.
A full report Rivastigmine Market of is available at: https://orionmarketreports.com/rivastigmine-market/92674/
Global Rivastigmine Market Report by Segment
By Disease Indication
•Alzheimer Disease
•Parkinson's Disease
By Formulation
•Capsules
•Transdermal Patches
By Distribution Channel
•Hospital Pharmacies
•Retail Pharmacies
•Online Pharmacies
Key questions addressed by the report
•What is the market growth rate?
•Which segment and region dominate the market in the base year?
•Which segment and region will project the fastest growth in the market?
•How has COVID-19 impacted the market?
•Deviation from the pre-COVID-19 forecast
•Most affected region and segment
•Who is the leader in the market?
•How players are addressing challenges to sustain growth?
•Where is the investment opportunity?
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rivastigmine Market Trends, Business Overview, Industry Growth and Forecast to 2028 here
News-ID: 2586701 • Views: …
More Releases from Orion Market Research
Image Recognition In CPG Market Current Status, In-depth Analysis and Forecast O …
The global image recognition in CPG market is expected to grow at a significant CAGR during the forecast period (2024-2031). The increasing need for efficient and profitable retail execution processes with adherence to compliance standards is one of the major factors expected to drive the growth of this market.
Image recognition solutions are revolutionizing the way CPG companies manage customer interactions, market products online and offline, and manage store inventory. Image…
Optical Communication Components Systems Market Demand Analysis, Type, Statistic …
The global optical communication components systems market is expected to grow at a significant CAGR during the forecast period (2024-2031). Rising adoption of cloud-based services and virtualization services all over the world, increasing data traffic due to increased internet usage, and a growing number of data centers are the major factors that are boosting the optical communication components systems market.
Get Free Sample link @ https://www.omrglobal.com/request-sample/optical-communication-components-systems-market
Moreover, some other factors that fuel…
Tamping Rammers Market Size, Share, Analysis, Applications, Growth Insight, and …
The global tamping rammers market is expected to grow at a significant CAGR during the forecast period (2024-2031). The increasing population in Asian countries and their requirement to access modern facilities such as good transportation are considered as an opportunity for the global tamping rammers market. The increasing number of vehicles is expected to increase the demand for road construction and road maintenance, subsequently driving the demand for tamping rammers…
Unmanned Ground Vehicles Market Trends, Business Overview, Industry Growth and F …
The global unmanned ground vehicles market is expected to grow at a significant CAGR during the forecast period (2024-2031). There is a growing use of UGVs to carry out counter-insurgency and combat operations. This is primarily to reduce human casualties in such situations. UGVs are also being used in various missions to enhance military situational awareness in urban warfare in conjunction with UAVs. The demand for UGVs is also increasing…
More Releases for Alzheimer
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
Anti-β-Alzheimer Therapies Market : Consumption, Revenue, Applications With Maj …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer…
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer…
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Alzheimer Diagnostic Tests Market
GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports.
Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as…